Psarras, Antonios
Alase, Adewonuola
Antanaviciute, Agne
Carr, Ian M.
Md Yusof, Md Yuzaiful
Wittmann, Miriam http://orcid.org/0000-0003-2328-4926
Emery, Paul http://orcid.org/0000-0002-7429-8482
Tsokos, George C. http://orcid.org/0000-0001-9589-2360
Vital, Edward M. http://orcid.org/0000-0003-1637-4755
Funding for this research was provided by:
DH | NIHR | Research Trainees Coordinating Centre (CS-2013-13-032, DRF-2014-07-155)
Article History
Received: 17 December 2018
Accepted: 28 October 2020
First Online: 1 December 2020
Competing interests
: M.W. declares that they have received honoraria for educational activity and consultancy from Novartis, Janssen, Abbvie, and Celgene. P.E. declares that they have received consultancy fees from BMS, Abbott, Pfizer, MSD, Novartis, Roche, and UCB, and research grants paid to their employer from Abbott, BMS, Pfizer, MSD, and Roche. G.C.T. declares that they have received consultancy fees from Jansen and is on the Scientific Advisory Boards of Silicon Pharmaceuticals and ABPRO. E.M.V. declares that they have received consultancy fees from Roche, GSK, Lilly, and AstraZeneca, and research grants paid to his employer from Roche and AstraZeneca. The remaining authors declare no competing interests.